Cargando…

Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study

INTRODUCTION: Patients with distributive shock who require high dose vasopressors have a high mortality. Angiotensin II (ATII) may prove useful in patients who remain hypotensive despite catecholamine and vasopressin therapy. The appropriate dose of parenteral angiotensin II for shock is unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chawla, Lakhmir S, Busse, Laurence, Brasha-Mitchell, Ermira, Davison, Danielle, Honiq, Jacqueline, Alotaibi, Ziyad, Seneff, Michael G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212099/ https://www.ncbi.nlm.nih.gov/pubmed/25286986 http://dx.doi.org/10.1186/s13054-014-0534-9

Ejemplares similares

The use of angiotensin II in distributive shock
por: Chawla, Lakhmir S., et al.
Publicado: (2016)

Angiotensin II may be useful for the treatment of hypotension in distributive shock, but a safe and efficacious dose is unknown
por: Busse, LW, et al.
Publicado: (2014)

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial
por: Ham, Kealy R., et al.
Publicado: (2019)

Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury
por: Chawla, Lakhmir S, et al.
Publicado: (2013)

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial
por: Wieruszewski, Patrick M., et al.
Publicado: (2023)

Strong ion gap can be accurately estimated with a simple bedside equation
por: Busse, L, et al.
Publicado: (2013)

Anion gap, anion gap corrected for albumin, base deficit and unmeasured anions in critically ill patients: implications on the assessment of metabolic acidosis and the diagnosis of hyperlactatemia
por: Chawla, Lakhmir S, et al.
Publicado: (2008)

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
por: Tumlin, James A., et al.
Publicado: (2018)

Reply to Picod et al.: Alteration of the Renin–Angiotensin–Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3
por: Chawla, Lakhmir S.
Publicado: (2021)

las seis mil barbas de Athos
por: Brewster, Ralph H.
Publicado: (1949)

Angiotensin converting enzyme defects in shock: implications for future therapy
por: Chawla, Lakhmir S., et al.
Publicado: (2018)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Amplitude analyses for CPV and $\gamma$ measurements PWA12/ATHOS7 2021
por: D'Argent, Philippe
Publicado: (2021)

The SwissFEL soft X-ray free-electron laser beamline: Athos
por: Abela, Rafael, et al.
Publicado: (2019)

Angiotensin II: a new therapeutic option for vasodilatory shock
por: Bussard, Rachel L, et al.
Publicado: (2018)

Acute appendicitis: transcript profiling of blood identifies promising biomarkers and potential underlying processes
por: Chawla, Lakhmir S., et al.
Publicado: (2016)

PWA 8 / ATHOS 3 The International Workshop on Partial Wave Analysis for Hadron Spectroscopy
Publicado: (2015)

Neurogenic pulmonary edema
por: Davison, Danielle L, et al.
Publicado: (2012)

Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety
por: Busse, Laurence W., et al.
Publicado: (2017)

Lactate concentration gradient from right atrium to pulmonary artery
por: Gutierrez, Guillermo, et al.
Publicado: (2005)

An empirical evaluation of a novel domain-specific language – modelling vehicle routing problems with Athos
por: Hoffmann, Benjamin, et al.
Publicado: (2022)

A compact gas attenuator for the SwissFEL ATHOS beamline realized using additive manufacturing
por: Pradervand, Claude, et al.
Publicado: (2023)

Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
por: Zarbock, Alexander, et al.
Publicado: (2021)

International Workshop on Partial Wave Analyses and Advanced Tools for Hadron Spectroscopy, PWA11/ATHOS6
Publicado: (2019)

ATHOS 2013 - International Workshop on New Partial-Wave Analysis Tools for Next-Generation Hadron Spectroscopy Experiments
Publicado: (2013)

The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
por: Busse, Laurence W., et al.
Publicado: (2017)

Broad spectrum vasopressors: a new approach to the initial management of septic shock?
por: Chawla, Lakhmir S., et al.
Publicado: (2019)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Angiotensin in Critical Care
por: Hall, Anna, et al.
Publicado: (2018)

Utilization of base deficit and reliability of base deficit as a surrogate for serum lactate in the peri-operative setting
por: Chawla, Lakhmir S, et al.
Publicado: (2010)

Carbon dioxide output in septic shock
por: Pilas, V, et al.
Publicado: (2005)

Opportunities and Barriers to Innovation in Acute Care Pediatrics
por: Chawla, Lakhmir S.
Publicado: (2020)

Permissive azotemia during acute kidney injury enables more rapid renal recovery and less renal fibrosis: a hypothesis and clinical development plan
por: Chawla, Lakhmir S.
Publicado: (2022)

Angiotensin II in septic shock
por: Corrêa, Thiago D, et al.
Publicado: (2015)

Eurozone Output Gaps and the COVID-19 Shock
por: Brooks, Robin, et al.
Publicado: (2020)

Angiotensin 1–7 in an experimental septic shock model
por: Garcia, Bruno, et al.
Publicado: (2023)

Angiotensin in ECMO patients with refractory shock
por: Ostermann, Marlies, et al.
Publicado: (2018)

Renal Stress Testing in the Assessment of Kidney Disease
por: Chawla, Lakhmir S., et al.
Publicado: (2016)

The Treatment of Shock by Intravenous Injections
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_gplu4s462v7ekfmhko718tc8lk